B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts

被引:160
作者
Hori, Junko
Wang, Mingcong
Miyashita, Megumi
Tanemoto, Keiko
Takahashi, Hiroshi
Takemori, Toshitada
Okumura, Ko
Yagita, Hideo
Azuma, Miyuki
机构
[1] Nippon Med Coll, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138602, Japan
[2] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan
[3] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan
[4] Tokyo Med & Dent Univ, Dept Mol Immunol, Tokyo 113, Japan
关键词
D O I
10.4049/jimmunol.177.9.5928
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The programmed death-1 (PD-1) costimulatory pathway has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. We investigated the role of this pathway in establishing an immune privilege status of corneal allografts in mice. B7-H1, but not B7-DC or PD-1, was expressed constitutively in the eye, i.e., cornea, iris-ciliary body, and retina. After corneal allografting, PD-1(+)CD4(+) T cells infiltrated and adhered with B7-H1(+) corneal endothelium. Blockade of PD-1 or B7-H1, but not B7-DC, led to accelerated corneal allograft rejection. In B7-H1-expressing corneal allografts, apoptosis of the infiltrating PD-1(+)CD4(+) or CD8(+) T cells was observed, after which there was allograft acceptance. In contrast, B7-H1 blockade suppressed apoptosis of infiltrating PD-1(+) T cells, which led to allograft rejection. In vitro, destruction of corneal endothelial cells by alloreactive T cells was enhanced when the cornea was pretreated with anti-B7-H1 Ab. This is the first demonstration that the constitutive expression of B7-H1 plays a critical role in corneal allograft survival. B7-H1 expressed on corneal endothelial cells maintains long-term acceptance of the corneal allografts by inducing apoptosis of effector T cells within the cornea.
引用
收藏
页码:5928 / 5935
页数:8
相关论文
共 56 条
[1]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[2]  
Apte RS, 1998, J IMMUNOL, V160, P5693
[3]  
BARKER CF, 1977, ADV IMMUNOL, V25, P1
[4]  
BOISJOLY HM, 1993, OPHTHALMOLOGY, V100, P1728
[5]  
BORA NS, 1993, INVEST OPHTH VIS SCI, V34, P3579
[6]   B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes [J].
Dong, HD ;
Zhu, GF ;
Tamada, K ;
Flies, DB ;
van Deursen, JMA ;
Chen, LP .
IMMUNITY, 2004, 20 (03) :327-336
[7]  
Dong HD, 1999, NAT MED, V5, P1365
[8]  
Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
[9]   Protect the killer: CTLs need defenses against the tumor [J].
Freeman, GJ ;
Sharpe, AH ;
Kuchroo, VK .
NATURE MEDICINE, 2002, 8 (08) :787-789
[10]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034